|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2006-12-4
|
|
pubmed:abstractText |
The long-term outcomes of interferon-alpha (IFN-alpha) therapy in hepatitis B e antigen (HBeAg) seropositive patients remain controversial. This study was conducted to address this issue.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0168-8278
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
46
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
45-52
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17107734-Adult,
pubmed-meshheading:17107734-Antiviral Agents,
pubmed-meshheading:17107734-Carcinoma, Hepatocellular,
pubmed-meshheading:17107734-Case-Control Studies,
pubmed-meshheading:17107734-Female,
pubmed-meshheading:17107734-Follow-Up Studies,
pubmed-meshheading:17107734-Genotype,
pubmed-meshheading:17107734-Hepacivirus,
pubmed-meshheading:17107734-Hepatitis B, Chronic,
pubmed-meshheading:17107734-Hepatitis B e Antigens,
pubmed-meshheading:17107734-Humans,
pubmed-meshheading:17107734-Interferon Type I,
pubmed-meshheading:17107734-Liver Cirrhosis,
pubmed-meshheading:17107734-Liver Neoplasms,
pubmed-meshheading:17107734-Male,
pubmed-meshheading:17107734-Recombinant Proteins
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma.
|
|
pubmed:affiliation |
Liver Research Unit, Chang Gung University and Chang Gung Memorial Hospital, Taipei, Taiwan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
